A metabolomic signature for predicting chemosensitivity in gastric cancer.

Francisco José García Verdejo,Ana Laura Ortega Granados,Caridad Díaz Navarro,Natalia Luque Caro,David Fernández Garay,Maria Carmen Álamo de la Gala,María Ruiz Sanjuan,Capilla de la Torre Cabrera,Monica Fernandez-Navarro,Rosario Dueñas García,Victor Navarro-Perez,Esther Martínez Ortega,Nuria Cárdenas Quesada,Ana Jaén Morago,Yéssica Plata-Fernández,Francisca Vicente Pérez,Olga Genilloud,Ana María Lozano Barriuso,Pedro Sánchez Rovira,José Pérez del Palacio

A metabolomic signature for predicting chemosensitivity in gastric cancer.

2017

e15504Background: Perioperative chemotherapy (QT) with platinum and fluoropyrimidines with or without anthracyclines is recommended option in patients with resectable gastric cancer (GC) at least c...

Keywords:

Cancer
Pathology
Metabolomics
Medicine
perioperative chemotherapy
Oncology
in patient
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations